These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30178714)

  • 21. Purification and kinetic properties of rabbit liver paraoxonase 1.
    Bayrak T; Bayrak A; Demirpençe E; Kilinç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1791-5. PubMed ID: 20627828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans.
    Jakubowski H
    Clin Chem Lab Med; 2003 Nov; 41(11):1462-6. PubMed ID: 14656026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of homocysteine, homocysteine thiolactone, and paraoxonase type 1 (PON-1) in the etiology of defective human sperm function.
    Aitken RJ; Flanagan HM; Connaughton H; Whiting S; Hedges A; Baker MA
    Andrology; 2016 Mar; 4(2):345-60. PubMed ID: 26825875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels.
    Jakubowski H
    FASEB J; 1999 Dec; 13(15):2277-83. PubMed ID: 10593875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of oak wood polyphenols on cysteine, homocysteine and glutathione total levels and PON1 activities in human adult volunteers - a pilot study.
    Deáková Z; Országhová Z; Andrezálová L; Slezák P; Lehotay J; Muchová J; Bürki C; Ďuračková Z
    Gen Physiol Biophys; 2015 Jan; 34(1):73-80. PubMed ID: 25367762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein N-homocysteinylation: implications for atherosclerosis.
    Jakubowski H
    Biomed Pharmacother; 2001 Oct; 55(8):443-7. PubMed ID: 11686577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
    Taler-Verčič A; Goličnik M; Bavec A
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrolysis of homocysteine thiolactone results in the formation of Protein-Cys-S-S-homocysteinylation.
    Silla Y; Varshney S; Ray A; Basak T; Zinellu A; Sabareesh V; Carru C; Sengupta S
    Proteins; 2019 Aug; 87(8):625-634. PubMed ID: 30869815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular basis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    Clin Chem Lab Med; 2007; 45(12):1704-16. PubMed ID: 17937605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
    Jakubowski H; Ambrosius WT; Pratt JH
    FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
    Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
    Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of paraoxonase and oxidative stress in adolescents with uraemic, essential or obesity-induced hypertension.
    Baráth A; Németh I; Karg E; Endreffy E; Bereczki C; Gellén B; Haszon I; Túri S
    Kidney Blood Press Res; 2006; 29(3):144-51. PubMed ID: 16912512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.
    Yilmaz N
    Arch Med Sci; 2012 Feb; 8(1):138-53. PubMed ID: 22457688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms that protect against homocysteine toxicity].
    Zimny J
    Postepy Biochem; 2008; 54(1):91-8. PubMed ID: 18610586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of homocysteine thiolactone in some of human diseases].
    Sikora M; Twardowski T; Jakubowski H
    Postepy Biochem; 2006; 52(4):417-23. PubMed ID: 17536511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification by homocysteine thiolactone affects redox status of cytochrome C.
    Perła-Kaján J; Marczak Ł; Kaján L; Skowronek P; Twardowski T; Jakubowski H
    Biochemistry; 2007 May; 46(21):6225-31. PubMed ID: 17474717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.
    Yang X; Gao Y; Zhou J; Zhen Y; Yang Y; Wang J; Song L; Liu Y; Xu H; Chen Z; Hui R
    Clin Chim Acta; 2006 Feb; 364(1-2):230-4. PubMed ID: 16111668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of homocysteinylation on high density lipoprotein physico-chemical properties.
    Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
    Chem Phys Lipids; 2010 Feb; 163(2):228-35. PubMed ID: 19962972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein N-homocysteinylation: From cellular toxicity to neurodegeneration.
    Sharma GS; Kumar T; Dar TA; Singh LR
    Biochim Biophys Acta; 2015 Nov; 1850(11):2239-45. PubMed ID: 26318987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.